Argenica Managing Director Dr Liz Dallimore described the decision as a key milestone in the company’s global regulatory strategy, noting that it provides clarity and certainty as ARG-007 progresses through development. …
EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe
February 2, 2026 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - - Australian Biotech -
Genetic Signatures appoints seasoned life sciences executive as CEO
February 2, 2026 - - Australian Biotech -
EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe
February 2, 2026 - - Australian Biotech -
Recce Pharmaceuticals deepens US partnership to advance burn wound treatment
February 2, 2026 - - Australian Biotech -
Another potential turning point for immunotherapy access in Australia
February 1, 2026 - - Latest News -
An announcement that cost more than the listing, because it would have actually cost something
February 1, 2026 - - Latest News -
Better Access Australia’s plan to make care fair, affordable and accountable
February 1, 2026 - - Latest News